Study treatment PPI ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 166 | Pseudoxanthoma elasticum | 1 |
166. Pseudoxanthoma elasticum
Clinical trials : 15 / Drugs : 27 - (DrugBank : 5) / Drug target genes : 5 - Drug target pathways : 28
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04868578 (ClinicalTrials.gov) | September 1, 2021 | 30/3/2021 | PyROphosPHate Supplementation to Fight ECtopIc Calcification in PseudoXanthoma Elasticum | PyROphosPHate Supplementation to Fight ECtopIc Calcification in PseudoXanthoma Elasticum: PROPHECI Study | Pseudoxanthoma Elasticum | Drug: study treatment PPI;Drug: Study comparator ETI | Centre Hospitalier Universitaire de Nice | NULL | Not yet recruiting | 18 Years | 65 Years | All | 99 | Phase 2 | France |